Key words
Bixa orellana
- Bixaceae - inflammation - nociception - myeloperoxidase - carrageenan
Introduction
Bixin ([Fig. 1]) is a major liposoluble diapocarotenoid extracted from the seeds of Bixa orellana Linné (Bixaceae). Among the natural carotenoids, bixin stands out chemically for
presenting the cis conformation, unusual among the carotenoids, and for presenting
a carboxylic group and a methyl ester in its chemical structure, which confers fat
solubility to the molecule [1], [2]. Bixin is widely used as an FDA-approved food colorant and additive, as well as
a cosmetic and textile colorant. It is considered the main pigment of the seeds of
annatto, the common name of the species B. orellana, being the greater responsible for conferring the reddish-orange tonality, characteristic
of seeds [3], [4]. Among the several plants that have these compounds and high colorant potential,
annatto is one of the most economically important plants [5].
Fig. 1 Chemical structure of bixin.
In Mexico and South America, B. orellana has been traditionally used to treat infectious and inflammatory diseases of the
skin, prostate, gastrointestinal tract, and chest pain [6]. In fact, several in vitro or in vivo studies have already demonstrated varied biological properties of B. orellana extracts or fractions, such as antibacterial, antifungal, antioxidant, and antimalarial
[1]. Importantly for this study, Benoit et al., (1976) [7] described a significant reduction of carrageenan-induced paw edema in rats after
treatment with ethanolic extract of B. orellana. Additionally, treatment with crude aqueous extract of B. orellana leaves exhibited significant inhibitory activity against bradykinin-induced inflammation
[8]. Considering the nociception, preliminary data obtained by Shilpi et al. (2006)
[9] have already demonstrated that methanol extract of B. orellana leaves significantly and dose-dependently reduced the acetic acid-induced writhing
response in mice.
Although bixin is the main carotenoid of B. orellana and that carotenoids are known compounds with several pharmacological properties
[10], [11], few studies evaluate the effects of isolated bixin. It has been already shown its
protective effect on cells and tissues with antioxidant, antimyeloma, antigenotoxicity,
and anti-clastogenicity actions, being considered a biological neutralizer of reactive
oxygen species [12]. In addition, studies have demonstrated the anti-inflammatory activity of bixin
through the antioxidant transcription factor Nrf2 activation [4], [13], and its efficiency in accelerating wound healing as well as reducing the scar tissue
area [14]. Although pain is one of the cardinal signs of inflammation, to our knowledge there
are no studies evaluating the antinociceptive potential of bixin. Thus, besides validating
its anti-inflammatory action, this study aimed to evaluate antinociceptive activities
of bixin in murine models of inflammatory pain.
Results
The [Fig. 2] (panel A) shows the effect of oral treatment with bixin (at doses of 15 or 30 mg/kg) or vehicle
(corn oil) on carrageenan (Cg) induced edema in rats. Two-way analysis of variance
(ANOVA) showed a significant effect on experimental groups [F(4, 35) = 16.74; p < 0.05] and time [F(4, 140) = 146.0; p < 0.05], besides an interaction between these 2 factors [F(16, 140) = 8.669; p < 0.05]. The post hoc test of Bonferroni showed a significant difference between all groups that received
Cg when compared with the vehicle (VEH)/saline (SAL)-treated group (p < 0.05), demonstrating
the Cg-induced increase in paw edema when compared to the SAL group peaking 2 and
3 h after Cg injection. Besides, the Bonferroniʼs test showed that the treatment with
bixin (30 mg/kg) significantly attenuated the paw edema at first and second hour after
Cg injection (p < 0.05). The paw edema in dexamethasone/Cg-treated group was significantly
different in comparison with vehicle/Cg-treated group, 2, 3, and 4 h after Cg injection
(p < 0.05).
Fig. 2 Effect of bixin or dexamethasone on carrageenan-induced paw edema in rats. Vehicle
(Veh; corn oil; 1 mL/kg, p. o.), bixin (Bix; 15 or 30 mg/kg, p. o.), or dexamethasone
(Dexa; 1 mg/kg, s. c.) was administered 1 h before carrageenan (Cg; 200 µg/paw in
0.1 mL of saline) treatment. Control group received Veh (equivalent volume) followed
by intra-plantar injection of saline (Sal; 0.1 mL/paw). Panel A shows the paw thickness (in mm) measured before (B) and 1, 2, 3, and 4 h after Cg
or Sal injection. Panel B shows the area under curve (AUC) in arbitrary units (AU) of total edema during the
4 h. The data represent mean + SEM (n = 8). * p < 0.05 compared to Veh + Sal-treated
group. # p < 0.05 compared to Veh + Cg-treated group.
Analyzing the area under the curve (AUC) of total edema during the 4 h after Cg treatment
([Fig. 2], panel B), 1-way ANOVA showed a significant effect on experimental groups [F(4, 35) = 15.87; p < 0.05]. The post hoc test of Bonferroni showed that all experimental groups treated with Cg were significantly
different when compared to the saline-treated group (p < 0.05). Additionally, this
test demonstrated that the experimental groups treated with bixin (dose of 30 mg/kg)
or dexamethasone were statistically different from the vehicle/Cg-treated group (p < 0.05),
but not different from each other (p > 0.05).
[Fig. 3] shows the effect of oral treatment with bixin (at doses of 15 or 30 mg/kg) or vehicle
(corn oil) on the myeloperoxidase (MPO) activity. One-way ANOVA showed a significant
effect on experimental groups [F(4, 30) = 14.92; p < 0.05]. The post hoc test of Bonferroni showed a significant difference between all groups that received
Cg injection in comparison to the VEH/SAL-treated group (p < 0.05). Therefore, the
injection of Cg causes an increase in MPO activity compared to the SAL group. Besides,
the Bonferroniʼs test showed a significant difference between bixin/Cg, at a dose
of 30 mg/kg, and dexamethasone/Cg-treated groups, in comparison to the vehicle/Cg-treated
group (p < 0.05). Thus, the treatment with bixin, at the dose of 30 mg/kg or with
dexamethasone was able to significantly reduce the MPO activity in comparison to the
VEH/Cg group (p < 0.05). No significant difference was observed between the bixin
(30 mg/kg) and dexamethasone/Cg-treated groups (p > 0.05).
Fig. 3 Effect of bixin or dexamethasone on MPO activity in rats. Vehicle (Veh, corn oil;
1 mL/kg, p. o.), bixin (Bix; 15 or 30 mg/kg, p. o.), or dexamethasone (1 mg/kg, s. c.)
was administered 1 h before carrageenan (200 µg/paw in 0.1 mL of saline) treatment.
Control group received Veh (equivalent volume) followed by intra-plantar injection
of saline (Sal; 0.1 mL/paw). The data represent means of relative OD + SEM (n = 7 – 8).
*p < 0.05 compared to Veh + Sal-treated group. # p < 0.05 compared to Veh + carrageenan-treated
group.
The [Fig. 4] (panel A) demonstrates the cumulative number of paw flinches induced by formalin injection
in rats treated with bixin (at doses of 15 or 30 mg/kg) or vehicle (corn oil). Two-way
ANOVA with repeated measures showed a significant effect on experimental groups [F(2, 21) = 99.37; p < 0.05] and time [F(11,231) = 314.4; p < 0.05], besides an interaction between these factors [F(22, 231) = 28.28; p < 0.05]. The post hoc test of Bonferroni showed a significant difference between bixin (at doses of 15
and 30 mg/kg) and VEH-treated group at all time points analyzed after formalin injection
(p < 0.05).
Fig. 4 Effect of bixin in formalin-induced nociception in rats. Vehicle (corn oil; 1 mL/kg,
p. o.) or bixin (Bix; 15 or 30 mg/kg, p. o.) was administered 1 h before formalin
(2.5%; 50 µL/rat). Panel A shows the number of formalin-induced cumulatively counted flinches for 60 min, divided
in 5 min counts. Panel B shows the total number of flinches exhibited during the first phase (phase I: 0 – 5 min),
quiescent interphase (6 – 15 min) and the second phase (phase II: 15 – 60 min) of
formalin test. The data represent mean + SEM (n = 7 – 9). *p < 0.05 compared to vehicle-treated
group. # p < 0.05 when compared to bixin-treated group (15 mg/kg).
Analyzing the total paw flinches response during the formalin test ([Fig. 4], panel B), 1-way ANOVA showed a significant effect on experimental groups during the phase
I [F(2, 21) = 54.46; p < 0.05] and phase II [F(2,21) = 28.41; p < 0.05], but not during the quiescent interphase [F(2,21) = 3.258; p > 0.05]. The post hoc test of Bonferroni showed that the bixin (at doses of 15 and 30 mg/kg) induces a
significant decrease of formalin-induced flinches compared to the VEH-treated group
(p < 0.05) during phases I and II of the formalin test, but not during the quiescent
interphase. No significant differences were observed between the doses of bixin during
phase I (p > 0.05). However, the number of flinches inhibited by the doses of bixin
were significantly different during phase II of the formalin test (p < 0.05).
The [Fig. 5] (panel A and B) demonstrates the number of writhings induced by acid acetic in mice treated with
bixin (at doses of 27 or 53 mg/kg) or vehicle (VEH; corn oil). Analyzing the time
course of acetic acid-induced writhings ([Fig. 5], panel A), 2-way ANOVA showed a significant effect on experimental groups [F(2, 28) = 31.87; p < 0.05] and time [F(5, 140) = 375.9; p < 0.05], besides an interaction between these factors [F(10, 140) = 17; p < 0.05]. The Bonferroni post hoc analysis showed a significant difference between bixin (at doses of 27 and 53 mg/kg)
and vehicle-treated group at 10, 15, 20, 25, and 30 min after acid acetic injection
(p < 0.05).
Fig. 5 Effect of bixin on acetic acid (AA)-induced writhing in mice. Vehicle (corn oil;
10 mL/kg, p. o.) or bixin (27 or 53 mg/kg) was administered 1 h before acetic acid
(AA; 0.6%; 10 mL/kg; i. p.) injection. Panel A shows the number of cumulatively counted writings induced by AA for 30 min, divided
in 5 min counts. Panel B shows the total AA-induced writhing responses during the 30 min. The data represent
mean + SEM (n = 9 – 11). * p < 0.05 compared to the vehicle-treated group. # p < 0.05
when compared to bixin-treated group (15 mg/kg).
When analyzed the total writhing response (panel B), 1-way ANOVA showed the effect
of the experimental groups [F(2, 28) = 31.31; p < 0.05] factor. The post hoc test of Bonferroni showed that bixin treatment at both tested doses significantly
reduced the number of acetic acid-induced writhings when compared to the VEH-treated
group (p < 0.05). Furthermore, the bixin doses also differ statistically from each
other (p < 0.05).
The [Fig. 6] (panel A) demonstrates the effect of bixin (at doses of 15 or 30 mg/kg) or vehicle (VEH; corn
oil) on the latency time in the hot plate apparatus. One-way ANOVA showed a significant
effect of the experimental groups [F(2, 37) = 4.061; p < 0.05] factor. The post hoc test of Bonferroni showed that bixin treatment (only at a dose of 30 mg/kg) induced
a significant increase in the latency time compared to the vehicle-treated group (p < 0.05).
Fig. 6 Effect of bixin in hot plate latency (panel A) and on number of crossings during the open field test (panel B) in rats. Vehicle (corn oil; 1 mL/kg, p. o.) or bixin (15 or 30 mg/kg, p. o.) was
administered 1 h before the behavioral tests. The data represent mean + SEM (panel
A, n = 13 – 14; panel B, n = 6 – 7). *p < 0.05 compared to the vehicle-treated group.
[Fig. 6] (panel B) shows the effect of bixin treatment (at doses of 15 or 30 mg/kg) or vehicle (VEH;
corn oil) on the number of crossings at the open field apparatus. One-way ANOVA show
no significant effect on experimental groups [F(2, 16) = 0.3298; p > 0.05].
Discussion
In the current study, the anti-inflammatory potential of bixin was validated using
preclinical models of acute inflammation. First, we demonstrated that oral treatment
with bixin was able to prevent the development of carrageenan-induced paw edema in
rats, which seems to be related to the inhibition of neutrophil migration to the inflammation
site. Besides, we observed, to our knowledge, for the first time in the literature,
the antinociceptive effect of acute treatment with bixin using preclinical models
of thermal and chemical nociception in rats and mice. This effect does not seem to
be associated with sedative effects since the bixin treatment did not change the locomotor
performance in the open field test. Additionally, the ability of bixin to attenuate
nociceptive responses induced by multiple stimuli (chemical and thermal) suggests
possible participation of the molecule in peripheral and central anti-nociceptive
mechanisms. This broad distribution of bixin is corroborated by previous findings
in the literature which indicate that as a nonpolar substance, bixin reaches the systemic
circulation (and therefore is detectable in plasma) 1 h later after oral administration
in an oily vehicle [15], [16].
Interestingly, previous studies have already demonstrated that B. orellana extracts or fractions significantly attenuate the inflammatory response induced by
diverse stimuli [8], [9]. When considering studies with isolated bixin, few in vivo and in vitro studies have also demonstrated the ability of bixin to reduce inflammation [13], [17], [18]. In our study, oral treatment with bixin promotes a significant reduction of paw
edema in the first and second hour after administration of carrageenan. As previously
described, paw edema induced by carrageenan produces a biphasic response [19] wherein the first phase (ranging from 0 to 60 min after administration of carrageenan)
is characterized by the release of substances such as histamine, serotonin and bradykinin
while the second phase (from 1, 2, and 3 h) is characterized by an increased production
and release of prostaglandins (PGs), as well as reactive species of oxygen from migratory
neutrophils [19], [20]. Considering this fact, our next experiment aimed to investigate the activity of
MPO, an enzyme released essentially by activated neutrophils, in the model of carrageenan-induced
inflammation. It was observed that bixin treatment significantly decreased the MPO
activity in carrageenan-inflamed skin samples, suggestive of a lower infiltration
of leukocytes to the injured tissue. Although not investigated in our study, previous
work has already shown that bixin significantly decreases the levels of inflammatory
markers such as interleukin 6 and tumor necrosis factor alpha [21] and reduces the in vitro activity of both cyclooxygenase isoforms activity, reducing the levels of PGs [17]. This anti-inflammatory effect of bixin has been also associated to its agonist
action on peroxisome proliferator-activated receptor (PPAR) alpha and PPAR gamma,
which, among other actions, promote the reduction of inflammatory cytokines and inhibition
of macrophage activation [18]. Finally, it has been described some cytoprotective effects of bixin due to its
activation of the transcription factor NRF2 (nuclear factor-E2-related factor 2) [22], which regulates the expression of numerous antioxidants, anti-inflammatory, and
pro-survival genes [15], [17], [22].
Since pain is one of the cardinal signs of inflammation, our next experiments were
designed to characterize an antinociceptive potential of bixin, an effect still unheard
of in the literature. We first start testing the effect of bixin on the nociceptive
responses induced by formalin. The formalin test is characterized by 2 distinct phases
of nociceptive behavior [23]. The first phase, called neurogenic, begins shortly after the formalin injection,
remaining until 3/5 min, and occurs due to chemical stimulation of the nociceptors
by formaldehyde [24]. After occurs a quiescent period (6 – 15 min), and then the second phase (15 – 60 min)
begins. This second phase, called inflammatory, is characterized by the return of
nociceptive behaviors and the involvement of peripheral inflammatory mediators, which
sensitize primary and spinal sensory neurons, triggering the activation of nociceptors
[24]. The different properties of both phases allow this test to be widely used as a
tool to indicate possible mechanisms of action for drugs being tested in regards a
peripheral and/or a central mechanism of action [25]. In our study, bixin treatment (at both tested doses) induces a significant decrease
of formalin-induced flinches during phases I and II of the formalin test, but not
during the quiescent interphase, corroborating its anti-inflammatory activity and
suggesting that bixin exerts its antinociceptive effect acting peripherally and centrally.
To confirm this, we also test the effect of bixin on the acetic acid-induced writhing
in mice. It has been well described that the i. p. administration of acetic acid induces
hyperalgesia by promoting the release of noxious endogenous substances, such as cytokines,
PGs, substance P, and bradykinin, which are responsible for sensitization of nociceptorsʼ
nerve endings [26], [27]. After injurious stimulation, large amounts of various PGs are produced by polymorphonuclear
cells, especially neutrophils, enhancing biosynthesis and release thereof into the
peritoneal cavity [28], [29]. As mentioned, to our knowledge there are no studies involving nociception using
isolated bixin. However, Shilpi et al. [9] have also observed a decrease in the number of acetic acid-induced abdominal writhes
after the treatment with the foliar methanolic extract of B. orellana. Drugs with anti-inflammatory and antioxidant properties have been described as being
effective in decreasing nociceptive behaviors and PGs levels in the peritoneal cavity
in this nociception test. Although not thoroughly investigated in the present study,
the antinociceptive effect of bixin observed in this test is possibly due to its anti-inflammatory
and antioxidant properties [28], its capacity to negatively modulate PG production by cyclooxygenase (COX) inhibition
[17], [30], and its ability to reduce neutrophil migration (the reduction of MPO activity).
In contrast to previous findings, in this test, the effect of bixin was not dose-related
(i.e., the lower dose of bixin significantly reduced the total number of writhes performed
during the 30 min when compared to the higher dose). This fact may be attributed to
physiological and interspecific differences between the rats and mice since the acetic
acid-induced abdominal writhing test was the only one conducted in Swiss albino mice
in this study. Corroborating this hypothesis, the previous study from Pinzon-Garcia
et al. [31] has also not observed a dose-response effect of bixin treatment on wound healing
using Swiss mice as an animal model.
To confirm that the antinociceptive effect of bixin involves central nervous system
(CNS)-mediated mechanisms, in our next experiment, the effect of bixin was investigated
on the latency to noxious thermal stimulus in the hot plate test. It has been well
characterized that drugs that act exclusively by their peripheral actions, such as
COX inhibitors, do not significantly alter the behavioral responses in this test,
making this a widely used model to evaluate drugs with potential action on the CNS
[32]. Bixin treatment significantly increased the latency to the noxious thermal stimulus
in the hot plate, demonstrating that central mechanisms may contribute to the antinociceptive
effect exerted by bixin (at least at the higher dose). Especially because of this
possible effect on CNS and in studies involving nociceptive behaviors that depend
on the display of active motor behaviors, it is extremely important to rule out the
possibility that compounds have sedative effects. To elucidate whether the treatment
with bixin promotes any locomotor deficit, the open field test was performed. As shown,
the treatment with bixin (at both tested dose) did not alter the number of crossings
in the open field test, excluding the sedative effect as a contributor to the antinociceptive
responses observed in the formalin and hot plate tests. Curiously, Shilpi et al. [9] reported that the methanolic extract of the leaves of B. orellana promoted a decrease in locomotion in this behavioral test, which was not observed
using the isolated bixin.
In this study, we demonstrated the anti-inflammatory property of bixin. It seems to
be due to its capacity of bixin to reduce the neutrophil migration to the inflammatory
site. Furthermore, this is the first report showing the antinociceptive property of
bixin, which does not appear to be related to the sedative effect but is associated
with both peripheral and central actions. Further studies are necessary to characterize
the mechanisms involved in these effects.
The 1H and 13C NMR spectra and the absorption at the maximum lambda in the UV region of bixin are
available as Supporting Information.
Material and Methods
Plant material
B. orellana (annatto) seeds were collected at the Instituto Ambiental do Paraná (IAP) in Morretes,
Paraná, Brazil, in June and July 2015 (coordinates: COD 02548038/25°30′S, 48°49′W;
altitude: 59 m). The plant material was identified by Osmar dos Santos Ribas from
Municipal Botanical Museum of Curitiba, where a voucher specimen (#379.394) was deposited.
Permission to evaluate the bioactivities of the extracts from Brazilian plants was
granted by the Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renováveis
(# 02001.001165/2013-47).
Isolation of bixin
The seeds (1000 g ± 0.1) were dried at 50 °C, pulverized, and passed through a 35-mesh
sieve. The powdered material was extracted in a modified Soxhlet apparatus using increasing
polarity solvents (1 : 10; w/v) (hexane, chloroform, ethyl acetate, and ethanol) for
6 h and subsequently filtered through Whatman No. 41 filter paper. The red-purple
powder of bixin (yield: 5.1%) was obtained by extracting chloroform with hexane from
the previously defatted seeds [14], [33]. The polarity gradient was performed to certify that bixin would not be present
in other solvents such as ethyl acetate and ethanol. The material was oven-dried and
stored at − 16 °C. The measured melting point of bixin (195 °C) was similar to previously
described in the literature [3], [14], [34].
Bixin identification
The bixin identification was supported by nuclear magnetic resonance spectroscopy
(NMR; 1H and 13C; Fig. 1S and Fig. 2S, Supporting Information) as well as by UV (Fig. 3S, Supporting Information) and IR [3], [35]. The purity of bixin was estimated to be greater than 99%. In agreement with the
literature [3], [36], [37], our results showed UVλ, nm: 489, 462, 432,7. IR ʋ(KBr) cm-11716.64, 1660, 1614, 1385, 1300, and 900. 1H NMR (600 M Hz. DMSO-d6), δ 7.89 (1H, d, J = 15.5 Hz, H-7), δ 7.26 (1H, d, J = 15.5 Hz, H-7′), 6.45 – 6.87 (10 H, m, 10 x: CH), 5.83 (1H, d, J = 15.5 Hz,
H-8), 5.94 (1H, d, J = 15.5 Hz, H-8′), 3.70 (3H, s, OMe), 1.92 – 1.99 (12 H, m, 4 x:
CMe).
In vivo experiments
Animals
Adult male Wistar rats (180 – 220 g) and Swiss albino mice (18 – 35 g), supplied by
the Federal University of Parana colony, were used in this study. Animals were housed
in plastic cages (41 × 32 × 16.5 cm) and maintained in standard conditions of room
temperature (21 ± 2 °C) and illumination cycle (12-h light/dark) with food and water
provided ad libitum. Bixin (15 or 30 mg/kg in rats; 27 or 53 mg/kg in mice, calculated
according to its basal metabolic rate, using the method proposed by Freitas and Carregaro
[38]) or vehicle (1 mL/kg; corn oil) was administered orally by gavage after 12-h fasting.
Animals were habituated to the experimental room for at least 1 h before the experiments.
The study was conducted following the National Institutes of Health Guide for the
Care and Use of Laboratory Animals and approved by the Federal University of Parana
Institutional Committee on the Ethical Use of Animals (CEUA/BIO-UFPR; authorization
#1087, approved on August 15, 2017). All efforts were made to minimize the number
of animals, following the reduction principle recommended by Russell and Burch [39]. For this reason, pharmacological positive control groups were not conducted for
behavioral experiments related to the potential antinociceptive effect of bixin since
the antinociceptive effect of drugs such as non steroidal anti-inflammatory drugs
(NSAIDs) or opioids has been extensively observed using the same animal models [40], [41].
Carrageenan-induced paw edema and measurement of the MPO activity
To evaluate the potential anti-inflammatory effect of bixin, the paw edema was induced
by intra-plantar injection of carrageenan (Cg; Sigma-Aldrich; purity: approximately
52%), at the dose of 200 µg/paw in 0.1 mL of saline, according to previously described
by Hirota et al. [42]. Briefly, 4 experimental groups were designed (n = 8 rats/each): negative control
group orally (p. o.) treated with corn oil (bixin vehicle; equivalent volume); bixin-treated
groups (15 or 30 mg/kg; p. o.); and positive control treated with dexamethasone (1 mg/kg,
subcutaneous injection). All treatments were administered 1 h before the injection
of carrageenan. Bixin doses were selected based on previous studies [4], [13], [14]. As a control, contralateral paws received saline (Cg vehicle; 0.1 mL). The paw
thickness was evaluated before (basal measurement) and again 1, 2, 3, and 4 h after
Cg or saline (0.1 mL/paw) injections, using a digital pachymeter and expressed in
millimeters (mm).
In another set of experiments, all the above experimental groups and procedures were
repeated. However, 3 h after Cg (peak of edema) or saline injections, rats were euthanized
and segments of the sub-plantar region of both hind paws were collected, weighed and
stored at − 80 °C. The MPO activity was determined according to the methodology described
by De Young et al. [43] with modifications. In brief, tissue samples were homogenized in 1.5 mL of sodium
phosphate buffer (80 nM, 0.5% hexadacyl trimethylammonium bromide [HTAB], pH 5.4)
for 15 s at 0 °C. The homogenate was then centrifuged at 11,200 g at 4 °C for 20 min. Then triplicates of 30 µL supernatant were transferred to plates,
which previously received 200 µL of peroxide solution (100 µL of 80 mM sodium phosphate
buffer, 85 µL of 0.22 mM sodium phosphate buffer plus 15 µL of hydrogen peroxide 0.017%).
The reaction was started with the addition of 20 µL of TMB solution (18.4 nM dissolved
in 8% aqueous dimethylformamide). The plate was then transferred to the greenhouse
for 3 min at 37 °C and thereafter the reaction was stopped by the addition of 30 µL
of sodium acetate (1.46 M) in each well. The enzymatic activity was evaluated by the
colorimetric method using a plate reader (Bio-Tek Ultra Microplate reader EL808),
with a wavelength of 620 nm. The results were expressed as optical density (OD)/total
sample weight.
Formalin test
The potential antinociceptive effect of bixin was firstly evaluated in the formalin
test according to Hirota et al. [42] with modifications. Briefly, 50 min after oral treatment with vehicle (corn oil;
1 mL/kg) or bixin (15 or 30 mg/kg), rats (n = 7 – 9 each group) were acclimated in
the formalin test apparatus (an inverted glass funnels 290 mm wide and 410 mm high)
for 10 min. Then animals received the formalin injection (2.5%, 50 µL/rat) into the
dorsal surface of one of the hind paws. Flinches were scored immediately after formalin
injection for 60 min, divided into 5-min periods with the phases defined as the following
time intervals: phase I (0 – 5 min), quiescent phase (6 – 15 min), and phase II (16 – 60 min).
Results were expressed as the cumulative number of flinches during the 60 min of the
test and the sum of total flinches at each phase of the test.
Acetic acid-induced writhing test
The writhing test was performed following the procedures previously described by Hirota
et al. [42]. For this, 50 min after oral treatment with vehicle (corn oil; equivalent volume;
p. o.) or bixin (27 or 53 mg/kg; p. o.), mice (n = 10 – 11 each group) were placed
to acclimate in an inverted glass funnel (290 mm wide and 410 mm high) for 10 min.
The doses of bixin used in mice were calculated according to the general method of
calculation for the allometric scale of drugs, based on the basal metabolic rate of
the animals [32]. One hour after the vehicle or bixin treatment, each mouse was injected with acetic
acid 0.6% (10 mL/kg; i. p. injection) and individually housed in the glass cylinder.
The cumulative number of writhes (characterized by abdominal constriction and stretching
of at least 1 hind limb) was scored for 30 min.
Hot plate test
The potential antinociceptive effect of bixin over an acute thermal stimulus (50 ± 1 °C)
was evaluated using a hot plate apparatus (Ugo Basile SRL), as previously described
[44]. For this, rats (n = 6 – 7 each group) were divided into 3 different groups treated
with vehicle (corn oil; 1 mL/kg; p. o.) or bixin (15 or 30 mg/kg; p. o.). The latency
(in seconds) for animals to display behaviors such as licking of the fore and hind
paws or jumping was measured before and 1 h after corn oil or bixin treatments. The
cutoff time used to prevent skin damage was 25 s.
Open field test
The open field test was conducted to evaluate the effect of treatments over the spontaneous
locomotor activity, according to Meotti et al. [45]. Briefly, 1 h after treatment with vehicle (corn oil; 1 mL/kg, p. o.) or bixin (15
or 30 mg/kg, p. o.) rats (n = 6 – 7 each group) were placed in the center of the open
field apparatus (a rectangular wooden arena; 40 cm wide × 50 cm long × 63 cm high;
divided into 9 rectangular units). The locomotor activity was video recorded, and
the number of units crossed with all 4 paws was counted for 5 min.
Statistical analysis
The data were presented by the mean plus standard error of the mean (SEM) for 6 to
14 animals per group. Data were compared using 2-way ANOVA with repeated measures
(time-course behavioral data, where the independent factors used were treatment and
time) or 1-way ANOVA (column graphs). When appropriate, the post hoc analysis of Bonferroni was applied. The level of significance was established at
p < 0.05. All the tests were carried out using the GraphPad Prism program (version
6).
